Andere talen ImmunityBio, Inc.

Aandelen

IBRX

US45256X1037

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,77 ^USD	-6,88%		+8,67%	+34,86%

20/06	Sectorupdate: Gezondheidszorgaandelen donderdagmiddag gemengd	MT
20/06	Aandelen ImmunityBio stijgen na lancering van blaaskankerbehandeling Anktiva in VS	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Mixed Thursday Afternoon	20/06
ImmunityBio Shares Rise After Launch of Bladder Cancer Treatment Anktiva in US	20/06
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US	20/06
ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors	20/06
ImmunityBio, Inc. Announces the Initial Treatment of Multiple Patients in the United States to Receive Therapy with ANKTIVA	20/06
ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update	07/06
ImmunityBio - Connecting the Dots of ANKTIVA's Triangle Offense, A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast	20/05
Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast	17/05
ImmunityBio: Q1 Earnings Snapshot	10/05
ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment	07/05
ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®	07/05
ImmunityBio, Inc. Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®	07/05
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	06/05
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; ImmunityBio to Advance, Boeing to Decline	03/05
ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types	02/05
Immunitybio, Inc., Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin Across All Cancer Types	02/05
ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to Discuss ANKTIVA Approval in Fireside Chat at the Annual Conference of the American Urological Association	01/05
ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to Discuss ANKTIVA® Approval in Fireside Chat at the Annual Conference of the American Urological Association	30/04
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Tuesday; MicroStrategy, Tesla to Decline	30/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ImmunityBio, Inc.

Aandelen

IBRX

US45256X1037

Andere talen

Filters